Eastern tradition · Adaptogen Herb

Gynostemma (Jiaogulan) 绞股蓝

“Southern ginseng,” a Chinese herb whose gypenosides activate AMPK — the metabolic longevity pathway.

13ClinicalTrials.gov matched
10PubMed RCT records
5Meta-analysis records
11+PubMed records
GypenosidesKey active compound

Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.

Origin & tradition

Jiaogulan (绞股蓝) is traditionally drunk as a longevity tea in parts of southern China, associated with vitality in older populations.

Why longevity buyers care

Key active: Gypenosides (botanical extract).

Gypenosides are direct AMPK activators (the same energy-sensing pathway as metformin and berberine), studied for metabolic and lipid endpoints.

Effect summary

Studied health outcomes

Editorial summary — This table is curated by hand from published research consensus, not automatically calculated from our trial database. Grades reflect our interpretation of the literature. Treat as a starting point, not a definitive verdict. See the Evidence panel below for the underlying trial and paper counts sourced directly from ClinicalTrials.gov and PubMed.
Health outcomeEffectMagnitudeGrade
Total and LDL cholesterolDecreasesModerateB
Fasting blood glucoseDecreasesModerateB
Antioxidant markersIncreasesMinorC
Fatigue / stress (adaptogenic)DecreasesMinorC

Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data

Dosage guidance

How Gynostemma (Jiaogulan) is typically used

Typical dose
450–900 mg/day extract or 3–6 g dried herb (as tea)
Form
capsule or loose-leaf tea (jiaogulan)
Timing
any time; traditional use is as daily tea

Jiaogulan tea is a traditional longevity drink from Guizhou, China. Gypenosides are the active compounds. Affordable and pleasant-tasting — reasonable as a daily tea substitute.

Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.

Evidence summary

What the research actually says

70Evidence confidence
Human RCT evidence10 randomized controlled trials · 5 meta-analyses / systematic reviews

Human metabolic RCTs (small); AMPK mechanism

Gypenosides are direct AMPK activators (the same energy-sensing pathway as metformin and berberine), studied for metabolic and lipid endpoints.

13registered clinical trials reference this intervention
    3selected from 11+ PubMed papers (longevity / aging angle)
    Key active: Gypenosides (botanical extract) — a multi-compound botanical extract, so activity is not reducible to a single molecule.

    According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-07-19. They include trials across many endpoints, not only longevity.

    Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.

    Compare the evidence

    Related ingredients

    Suppliers

    1 suppliers in our directory carry Gynostemma (Jiaogulan)

    Request sourcing help